Business
Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate Update
STOUGHTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the
About this update from Collegium Pharmaceutical, Inc.
[{"type":"text","content":"STOUGHTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, confirmed today the details of the year-end earnings call, previously announced on February 13, 2020. The company will host a conference call and live audio webcast on Thursday, February 27, 2020 at 4:30 p.m. Eastern Time. The company will discuss its financial results for the Fourth Quarter and Full-Year 2019 and provide a corporate update. \n Conference Call Information: To access the conference call, please dial (888) 698-6931 (U.S.) or (805) 905-2993 (International) and refer to Conference ID: 829-8360. An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event. About Collegium Pharmaceutical, Inc. Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. Contact: Alex Dasalla [email protected]\n\n\nSource: Collegium Pharmaceutical, Inc.","length":2916,"tagName":"div"}]